PIKA uses multiple specialized AI agents to monitor Parkinson's symptoms around the clock, interpret them against clinical guidelines, and surface what matters to patients, caregivers, and clinicians.
Parkinson's disease affects over 10 million people worldwide, and that number is projected to double by 2040. Beyond the motor symptoms most people know about, PD causes treatable complications like depression, sleep disruption, and hallucinations that quietly erode quality of life.
Yet care still depends on brief clinic visits weeks or months apart. Between visits, there is no structured monitoring. Clinicians make decisions from incomplete snapshots, and existing digital tools collect more data without helping anyone make sense of it.
Brief clinic visits months apart miss symptom changes. Patients struggle to recall or articulate evolving patterns.
Wearables and apps generate numbers but don't evaluate them against clinical guidelines. More data, more noise.
Patients, caregivers, and clinicians operate in silos. Nursing triage lines are overwhelmed.
PIKA goes beyond data collection. It interprets symptoms, reasons about their clinical significance, and acts on validated guidelines.
An orchestrating Ambient Care Agent coordinates three specialists: a Clinical Insight Engine for symptom analysis, a Routine Manager for medication and scheduling, and a Companion Agent for daily engagement. All operate under a 4-tier safety escalation model.
Every agent embeds validated clinical scales and threshold logic. Instead of asking "what does the data show?", the system asks "does this warrant a change in care?" Clinical decision-making is built into the AI, not layered on top.
All AI runs locally on the patient's device. No patient data leaves the machine. A modular SDK and app ecosystem let clinical teams extend the platform while preserving full privacy compliance.
Rather than one monolithic model, PIKA uses purpose-built agents that collaborate through shared memory, each focused on a specific aspect of patient care.
Symptom-domain analyzers that evaluate patient data against encoded clinical guidelines
Adaptive scheduling and autonomous care workflow management
Daily engagement and psychosocial support to combat isolation
The interface adapts to each role: patients get a care companion, clinicians get visit-ready briefs, and developers get full visibility into the AI engine layer.
A daily check-in session where the Companion Agent hands off to the Clinical Insight Engine for sleep and mood screening, with real-time agent routing visible throughout.
PIKA runs on Ferret, a local-first AI platform that handles multi-model inference, context assembly, memory, and application sandboxing so clinical teams can focus on care logic, not infrastructure.
Edge-native, privacy-preserving, clinically extensible
Seven inference engines (llama.cpp, sherpa-onnx, whisper.cpp, ONNX Runtime, stable-diffusion.cpp, LiteRT-LM, MLX) handle speech, vision, generation, and classification through a single task API.
Memories decay, reconsolidate, and surface based on relevance, modeled after how human memory actually works: spacing effects, event segmentation, surprise-gated encoding, and spreading activation.
TypeScript and Python APIs for building apps, skills, agents, and workflows. Third-party apps run sandboxed with per-app permissions and hot-reload during development.
Policy-gated actions, role-based access, consent management, and full trace logging for every AI decision. Designed for PIPEDA, BC PIPA, and SaMD compliance.
PIKA is already in clinical use. Here's where we are and where we're headed.
PIKA's architecture is modular by complication, not by disease. The same agent framework can extend to Alzheimer's, multiple sclerosis, and other chronic neurological conditions with new guideline profiles rather than new infrastructure.
Because all inference runs locally, PIKA sidesteps the biggest barrier to healthcare AI adoption: data privacy. The system is designed to meet PIPEDA, GDPR, and Chinese data protection regulations without architectural changes.
Patients interact through natural conversation instead of complex forms. Daily companionship combats social isolation. Medication reminders and exercise prompts provide value every single day.
Caregivers receive timely, structured updates instead of anxious guesswork. Clinicians get prioritized, guideline-referenced briefs that make each visit more focused and productive.
Clinical neurology, machine learning research, and industry deployment, working together at the University of British Columbia.



On-device AI platform awarded top position by OpenCV and Intel for privacy-preserving edge architecture.
AI technology portfolio foundational to PIKA's on-device AI approach.
Perplexity-Guided Self-Correction for LLMs. Peer-reviewed at a top-tier AI venue.
Work on ethical AI governance in PD digital health, published in AJOB Empirical Bioethics (2023) and AI & Society (2024).
Pre-assessment chatbot used by real PD patients at the VCH Movement Disorders Clinic.
Pacific Parkinson's Research Centre holds this designation, recognizing world-class PD research and care.
Moving beyond episodic clinic visits to always-on, guideline-aware monitoring and support.